Application Sponsors
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | 80% | 0 | ANGIO-CONRAY | IOTHALAMATE SODIUM |
FDA Submissions
TYPE 2; Type 2 - New Active Ingredient | ORIG | 1 | AP | 1996-04-26 | STANDARD |
LABELING; Labeling | SUPPL | 19 | AP | 1996-04-26 | |
LABELING; Labeling | SUPPL | 21 | AP | 1976-05-06 | |
LABELING; Labeling | SUPPL | 22 | AP | 1996-04-26 | |
LABELING; Labeling | SUPPL | 24 | AP | 1996-04-26 | |
LABELING; Labeling | SUPPL | 25 | AP | 1996-04-26 | |
LABELING; Labeling | SUPPL | 27 | AP | 1982-10-19 | |
LABELING; Labeling | SUPPL | 30 | AP | 1985-04-16 | |
LABELING; Labeling | SUPPL | 33 | AP | 1989-06-28 | |
CDER Filings
MALLINCKRODT
cder:Array
(
[0] => Array
(
[ApplNo] => 13319
[companyName] => MALLINCKRODT
[docInserts] => ["",""]
[products] => [{"drugName":"ANGIO-CONRAY","activeIngredients":"IOTHALAMATE SODIUM","strength":"80%","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"ANGIO-CONRAY","submission":"IOTHALAMATE SODIUM","actionType":"80%","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)